Rejuran vs Skin Vibe vs Jubelook: Comparing Mason Clinic's Skin Boosters

Rejuran vs Skin Vibe vs Jubelook: Comparing Mason Clinic's Skin Boosters

Medically reviewed by Dr. Hyunju Kim, Medical Director, Mason Clinic

"Skin booster" has become a catch-all phrase, and that is exactly what makes it confusing. When someone researching treatment in Seoul sees Rejuran, Skin Vive, and Jubelook listed side by side, it is easy to assume they are interchangeable versions of the same idea. They are not. Each is built around a different primary mechanism, aims at a different goal, and suits a different set of concerns. This guide compares the three skin boosters documented at Mason Clinic by how they work and what they set out to do, so you can walk into a consultation with sharper questions rather than a name you picked at random.

A few things up front. This article is educational and is not a self-diagnosis tool. It does not name a winner, because there is no single booster that is right for everyone; the appropriate choice depends on your skin and your goals, assessed in person. Just as importantly, this is a comparison of injectable treatments that are offered at Mason Clinic's Seoul location, and their United States regulatory status matters. As you will read below, none of these three is a US-FDA-approved product, and one carries a naming caution that is easy to get wrong. Results vary from person to person, injectable treatments carry their own risks, and none of these boosters is a dermal filler.

What a "Skin Booster" Is, and What It Is Not

It helps to define the category before comparing products within it. At Mason Clinic, skin boosters are injectable treatments intended to improve the quality of the skin itself: its hydration, texture, tone, firmness, and overall condition. That is a different objective from a dermal filler. A filler is placed to add volume and reshape or support a specific area, such as a cheek or a lip. Skin boosters, by contrast, are about the character and condition of the skin across a treated zone rather than about building structure or contour. Keeping that distinction in mind prevents a common misunderstanding: none of the three treatments compared here is being described as a filler, and none is a substitute for one.

Within that shared category, the three products diverge on their primary mechanism. Rejuran centers on skin-repair using a polynucleotide (PDRN) ingredient. Skin Vive centers on hydration. Jubelook centers on collagen stimulation. Those three verbs, repair, hydrate, and stimulate, are the clearest way to keep the comparison straight, and the sections that follow take each in turn before setting them next to one another.

Rejuran: A PDRN Polynucleotide Skin Booster

Rejuran is a skin booster built around PDRN, or polynucleotide, a material that is salmon-derived. At Mason Clinic it is documented in more than one form. Rejuran HB Plus is presented as a booster that focuses on restoring the skin by improving a damaged skin environment, strengthening the skin barrier, providing deep hydration, and improving overall skin texture and tone. Eyerejuran, the eye-area version, is described as a solution intended to improve fine lines and elasticity around the eyes while revitalizing thin under-eye skin. In broad terms, patients considering Rejuran are typically focused on skin condition, skin-barrier support, hydration, fine lines, and the quality of delicate areas such as under the eyes.

The regulatory picture is where readers in the United States need to be especially careful, because it is genuinely easy to conflate two different things. Injectable Rejuran is not US-FDA-approved. In 2022 the FDA issued a caution regarding injectable Rejuran products. Separately, some topical cosmetics containing c-PDRN are sold in the United States, but a topical cosmetic is a completely different category from an injectable treatment. The fact that a topical PDRN product may be available on a shelf in the US does not mean the injectable Rejuran treatment offered in Seoul shares that status, and this article does not represent injectable Rejuran as FDA-approved. If you have seen PDRN or "salmon DNA" products marketed in the US, do not assume they are the same as the injectable treatment discussed here.

Skin Vive: A Hydration-Focused Skin Booster (With a Naming Caution)

Skin Vive is presented by Mason Clinic as a skin booster focused on achieving a moist, hydrating glow that fills the skin from within. The clinic states that it improves skin hydration and radiance, improves skin texture and tone, and helps maintain elasticity. In terms of who tends to look into it, the clinic describes it as suited to people concerned about dull and dry skin, people with rough skin or whose makeup does not go on well, and those who want naturally moist, glossy-looking skin. If the previous product is best summarized by the word "repair," this one is best summarized by "hydration."

Now the naming caution, which is important enough to state plainly. The clinic's hydration booster is documented as "Skin Vive." There is a separately FDA-approved product on the US market named "SkinVive by Juvederm," made by Allergan. Do not assume the two are the same product. The clinic's "Skin Vive" is not confirmed to be FDA-approved, and the similarity of the names is not evidence that it is the Allergan product. Because product naming across markets can be genuinely confusing, the honest step is to route this specific question to the clinic and ask staff to confirm exactly which product would be used in your treatment. This article does not represent the clinic's Skin Vive as being the FDA-approved SkinVive by Juvederm, and it does not represent it as FDA-approved.

Jubelook: A Collagen-Stimulating Skin Booster

Jubelook Skin Booster is described by the clinic as a treatment that aims to stimulate collagen production and improve skin elasticity, with the intent of helping reduce the appearance of pores, improving skin texture, and restoring a firmer, more radiant skin tone. The clinic lists it as suited to people concerned about fine lines, enlarged pores, and reduced skin elasticity; those seeking longer-term skin improvement through consistent treatment; and individuals who want preventive care in the early stages of skin aging. Where Rejuran's keyword is "repair" and Skin Vive's is "hydration," Jubelook's is "collagen stimulation."

On regulatory status, the point is short and unambiguous: Jubelook is not US-FDA-approved. It is a collagen-stimulating injectable booster offered at Mason Clinic's Seoul location. As with the other two, a product may hold approvals or registrations in Korea or elsewhere, but approvals granted in other countries are not equivalent to US FDA approval, and this article does not present Jubelook as FDA-approved.

Side by Side: Matching Mechanism and Goal to Your Concern

With each product defined on its own, the comparison becomes clearer. The most useful way to hold the three in mind is by primary mechanism and the concern each is documented to target.

Rejuran is the PDRN, or polynucleotide, option, salmon-derived, oriented toward skin-repair: supporting a damaged skin environment, strengthening the skin barrier, deep hydration, and texture and tone, with a dedicated eye-area version for the delicate under-eye zone. Skin Vive is the hydration option, oriented toward a moist, radiant, glass-like quality and directed at dull, dry, or rough skin and the wish for naturally glossy skin. Jubelook is the collagen-stimulation option, oriented toward elasticity, pore appearance, texture, and firmer tone, and framed by the clinic partly as preventive care in the early stages of skin aging.

Where do these overlap, and where do they part ways? All three touch on texture and tone in some fashion, which is part of why they can look interchangeable at a glance. But the underlying intent differs: one is about repairing and supporting the skin environment, one is about internal hydration and glow, and one is about prompting collagen. A person whose main frustration is chronic dryness and dullness is asking a different question from someone focused mainly on early elasticity changes and pore appearance, and a different question again from someone prioritizing skin-barrier support or the fragile under-eye area. That is why matching mechanism to concern, rather than picking the most familiar name, is the sensible approach.

It is worth repeating that this comparison is not a ranking. None of the three is "stronger" or "better" in the abstract, and the right answer for one person's skin can be the wrong answer for another's. The purpose here is orientation, not prescription.

Why an Ultrasound-Based Consultation Comes First

At Mason Clinic, injectable skin-booster treatment is preceded by an individualized assessment rather than a fixed menu choice. The clinic describes evaluating each patient's anatomy, skin type, lifestyle, and aesthetic goals before a procedure begins, and it uses ultrasound imaging to assess skin thickness, the subcutaneous fat layer, and the underlying muscle structure. Patients who request a doctor's consultation can be seen by Dr. Kim, the clinic's medical director. This diagnostic-first step is the reason questions like "which skin booster is right for me" cannot be answered honestly from an article: the appropriate choice, or a decision that a booster is not the right route at all, follows from what the assessment reveals about your particular skin.

The clinic also describes practices intended to support safety and transparency around injectables: genuine products with proper dosage opened in front of the patient, photographic documentation of dosing, private treatment rooms, professional cleansing and aftercare, and a pain-minimization system that may include advanced PRESS devices, machine-assisted absorption of anesthetic cream, microneedle techniques, analgesic injections, and nerve anesthesia. The specific comfort measures used depend on the treatment plan and the individual patient.

Risks, Realistic Expectations, and What to Confirm

Because these are injectable treatments, they carry the considerations that come with any injection. Common, general injection-related effects can include redness, swelling, bruising, and tenderness at the treated sites. A fuller, treatment-specific list of risks, side effects, and precautions, along with guidance on who should avoid or postpone treatment, is something to confirm directly with the treating clinician during your consultation; those details are individualized to you and are not settled by a comparison article. If you are pregnant, breastfeeding, or managing any medical condition, raise that with the clinic as well.

Expectations deserve equal honesty. Skin boosters are intended to support skin quality gradually, and results vary between individuals. They are not guaranteed to produce a specific outcome, they are not a cure for skin aging, and they do not stop the underlying processes that change skin over time. Consistency and maintenance may be part of a longer-term plan, particularly for a treatment like Jubelook that the clinic frames partly around ongoing improvement. None of the three is a filler, so if your goal is volume or contour rather than skin quality, that is a different conversation to have with the clinic.

Finally, keep the regulatory summary front of mind, because it is the part most often blurred. For readers in the United States: injectable Rejuran is not US-FDA-approved and was the subject of a 2022 FDA caution, and it should not be confused with topical c-PDRN cosmetics sold in the US; the clinic's Skin Vive is not confirmed to be FDA-approved and should not be assumed to be the separately FDA-approved SkinVive by Juvederm from Allergan; and Jubelook is not US-FDA-approved. All three are offered at the Seoul location. Approvals or registrations granted in other countries are not equivalent to US FDA approval. This distinction is not a comment on quality; it is information you are entitled to when weighing care received abroad.

Bottom Line

Rejuran, Skin Vive, and Jubelook are three distinct skin boosters that are easy to lump together and better understood apart. Rejuran is a PDRN, polynucleotide, salmon-derived booster oriented toward skin-repair, barrier support, and hydration, with an eye-area version for the under-eye zone. Skin Vive is a hydration-focused booster aimed at a moist, radiant look for dull or dry skin. Jubelook is a collagen-stimulating booster aimed at elasticity, pore appearance, texture, and firmer tone. None is a dermal filler, and the right choice, if any, depends on your concern and an in-person assessment rather than on a name.

On regulatory status, the essentials for US readers are clear: injectable Rejuran is not US-FDA-approved (and is separate from topical c-PDRN cosmetics; note the 2022 FDA caution), the clinic's Skin Vive is not confirmed FDA-approved and is not to be assumed identical to the FDA-approved SkinVive by Juvederm, and Jubelook is not US-FDA-approved. All are offered in Seoul, results vary and are not guaranteed, and injection-related effects such as redness, swelling, bruising, and tenderness are possible. The productive next step is an individualized consultation, including ultrasound assessment, not a decision made from a comparison chart.

Frequently Asked Questions

**Are Rejuran, Skin Vive, and Jubelook the same type of treatment?**They share the "skin booster" category, meaning they are injectables intended to improve skin quality rather than add volume like a filler, but their primary mechanisms differ. Rejuran centers on PDRN-based skin-repair, Skin Vive on hydration, and Jubelook on collagen stimulation. Because they target different concerns, the appropriate choice depends on your skin and goals, assessed in person. This guide is educational and not a self-diagnosis tool.

**Are any of these three FDA-approved in the United States?**No. Injectable Rejuran is not US-FDA-approved, and the FDA issued a caution regarding injectable Rejuran in 2022; it should not be confused with topical c-PDRN cosmetics sold in the US. The clinic's Skin Vive is not confirmed to be FDA-approved and should not be assumed to be the separately FDA-approved SkinVive by Juvederm from Allergan. Jubelook is not US-FDA-approved. All three are offered at Mason Clinic's Seoul location.

**Is the clinic's "Skin Vive" the same as "SkinVive by Juvederm"?**Do not assume so. They have similar names, but the clinic's Skin Vive is not confirmed to be the FDA-approved SkinVive by Juvederm made by Allergan. Product naming across markets can be confusing, so ask the clinic directly to confirm exactly which product would be used in your treatment.

**Which booster is best for dry, dull skin versus early elasticity changes?**As a general orientation, Skin Vive is documented around hydration and radiance for dull or dry skin, while Jubelook is documented around collagen stimulation, elasticity, and pore appearance. Rejuran is oriented toward skin-repair and barrier support. That said, no booster is "best" in the abstract, and the right match is determined through an in-person assessment rather than from a list.

**What risks should I expect with these injectable boosters?**As injectables, they carry general injection-related considerations such as redness, swelling, bruising, and tenderness at the treated sites. A complete, treatment-specific list of risks and who should avoid or postpone treatment must be confirmed with the treating clinician during consultation, and results vary between individuals and are not guaranteed.

Disclaimer

This article is for general education only and is not a self-diagnosis tool or a substitute for professional medical advice. Individual candidacy, treatment selection, and suitability require an in-person consultation and ultrasound assessment at the clinic. Results vary between individuals and are not guaranteed, and every injectable treatment carries potential risks and side effects that should be discussed with a qualified clinician. Regulatory status differs by country: none of the three boosters described is US-FDA-approved, injectable Rejuran was the subject of a 2022 FDA caution and is distinct from topical c-PDRN cosmetics, and the clinic's Skin Vive should not be assumed to be the FDA-approved SkinVive by Juvederm. Approvals granted elsewhere are not equivalent to US FDA approval. Please consult Mason Clinic directly with your specific questions.